Clinical Evaluation of Systane® Gel Drops in Dry Eye Subjects

Inclusion Criteria: * Must give informed consent, and be willing and able to attend all study visits. * Best-corrected visual acuity (BCVA) of ≥ 55 letters in each eye as measured by ETDRS (letters read method). * Dry eye in both eyes diagnosed by an ophthalmologist. * Other protocol-specified inclusion criteria may apply. Exclusion Criteria: * Women of childbearing potential who are pregnant, test positive on a pregnancy test, or breast-feeding. * Any medical condition (systemic or ophthalmic) that may, in the opinion of the Investigator, preclude the safe administration of test article or safe participation in the study. * Any contraindications or hypersensitivities to the study medications or their components. * Ocular surgery (of any type, including PRK, LASIK, Epilasik, etc.) or ocular trauma requiring medical or pharmacological treatment within 1 year of Screening. * Use of topical ocular prescription or non-prescription medications, RESTASIS or topical ocular steroids within 14 days of Screening. * Chronic medications (over the counter, prescription, or vitamins) that have not been on a stable dose for at least 30 days prior to Screening. * Contact lens wear within 1 week of Screening and/or unwillingness to discontinue contact lens wear for the duration of the study. * Participation in any other clinical trial within 30 days prior to Screening. * Other protocol-specified exclusion criteria may apply.